EP2319925

Therapeutic uses of inhibitors of RTP801

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    16.8.2005
  • EP published:
    25.7.2018
  • EP application number:
    11153604.1
  • Max expiry date:
    15.8.2025
  • Title:
    Therapeutic uses of inhibitors of RTP801

Timeline

Today
16.8.2005EP application
25.7.2018EP Publication

Owner

  • Name:
    Quark Pharmaceuticals, Inc.
  • Address:
    6501 Dumbarton Circle, 94555, Fremont, California, US
  • Name:
    Silence Therapeutics GmbH
  • Address:
    Robert-Rössle-Strasse 10, 13125, Berlin, DE

Inventor

  • Name:
    Feinstein, Elena
  • Address:
    Rehovot, IL
  • Name:
    Kaufmann, Jörg
  • Address:
    Berlin, DE
  • Name:
    Giese, Klaus
  • Address:
    Berlin, DE

Priority

  • Number:
    601983 P
  • Date:
    17.8.2004
  • Country:
    US
  • Number:
    604668 P
  • Date:
    25.8.2004
  • Country:
    US
  • Number:
    609786 P
  • Date:
    14.9.2004
  • Country:
    US
  • Number:
    638659 P
  • Date:
    22.12.2004
  • Country:
    US
  • Number:
    664236 P
  • Date:
    22.3.2005
  • Country:
    US
  • Number:
    688943 P
  • Date:
    8.6.2005
  • Country:
    US
  • Number:
    04019405
  • Date:
    16.8.2004
  • Country:
    EP

Classification

  • Categories:
    C12N 15/113, A61K 31/713, A61P 11/00, A61P 27/00

Upload documents